Sponsor Pipeline

Shanghai Huaota Biopharmaceutical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
10
Active Trials
6
Recruiting
3
Phase 3
4
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 2/3
1
Phase 2
1
Phase 1/2
4
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07360132 Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Pembrolizumab… Squamous Non-small Cell Lung Cancer Not Yet Recruiting
NCT07383116 Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Tislelizumab… Non Squamous Non-small Cell Lung Cancer Not Yet Recruiting
Phase 2/3
NCT06477536 Long-Term Safety and Efficacy of HB0034 in Subjects With Generalized Pustular Psoriasis Generalized Pustular Psoriasis Recruiting
Phase 2
NCT06231381 Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP) Generalized Pustular Psoriasis (GPP) Recruiting
Phase 1/2
NCT05417321 A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid… Advanced Solid Tumor Recruiting
NCT06895499 Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients. Hidradenitis Suppurativa Recruiting
NCT06992687 A Study to Evaluate the Safety and Efficacy of HB0052 in Patients With Advanced Solid… Solid Tumors Enrolling by Invitation
NCT07449156 A Study to Evaluate Efficacy and Safety of HB0043 in Aadult Patients With Moderate to… Acne Vulgaris Not Yet Recruiting
Phase 1
NCT06716151 A Study to Evaluate HB0034 in Healthy Chinese Adult Participants Healthy Recruiting
NCT06612970 A Study to Evaluate Single-dose of HB0056 in Healthy Adult Participants Healthy Recruiting
Disease Areas
Get alerts when Shanghai Huaota Biopharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free